The Subsidy Is the Business Model Now: What the 2026 Anesthesia Stipend Boom Means for Anesthesiologists, CRNAs, and AAs

For most of the last three decades, anesthesia coverage was treated as a service line that paid for itself. A group billed base units and time units, the hospital provided the space, and the arrangement worked. That is no longer how the economics function. In 2026, the stipend — the check a hospital or ambulatory surgery center writes to guarantee coverage — has become the primary funding mechanism for operating room access. Everything else is increasingly a rounding error.

This is not a rhetorical claim. It is the best-documented trend in the anesthesia staffing market, and it changes where leverage actually sits for anesthesiologists, CRNAs, and certified anesthesiologist assistants.

The number that reframes the whole market

The strongest evidence comes from a peer-reviewed longitudinal study of California hospitals published in Health Affairs. Among hospitals paying an anesthesiology stipend, the mean annual stipend rose from roughly $648,000 in 2002 to $2.9 million in 2021. Over the same period, the share of California hospitals paying any anesthesiology stipend climbed from 35.5% to 57.4% (Duffy, Green & Trish, Health Affairs, June 2025; USC Schaeffer Center summary).

The most useful way to read that figure is per unit of work. Volume-standardized, the 2021 stipend worked out to $40.11 per 15 minutes of anesthesia services — against a Medicare payment of roughly $21.56 for the same increment (Becker's ASC). The subsidy was already paying nearly twice what the public payer paid. The professional fee had become the smaller half of the transaction.

Two caveats worth stating plainly: the data end in 2021, and they cover California. As a level, the figure is dated. As a direction, nothing since has reversed it — roughly 80% of hospitals now provide some form of anesthesia stipend.

Now it is the ASCs' problem

Stipends began as a hospital phenomenon, largely because hospitals could absorb the loss against downstream facility revenue. That containment has broken. Ambulatory surgery centers, which have far less margin to redeploy, are being pulled into the same arrangement.

• The share of ASCs expecting to pay anesthesia stipends jumped from 28% in 2024 to 44% in 2025, per VMG Health's ASC Leader Expectations for 2026 report (VMG Health; figures via Becker's ASC).
• 67% of ASC leaders ranked anesthesia coverage among their top three financial challenges for 2026 (ASC News).
• More than 80% of ASCs anticipate contractor-based anesthesia arrangements in 2026, with 44% expecting an independent-contractor-plus-stipend structure — and only 9% planning a traditional employment agreement (Becker's ASC).

That last statistic is the one to sit with. When 9% of a buyer segment plans to employ anesthesia clinicians directly, employment is no longer the default model — it is the exception. The consequence is already visible in throughput: in a 2026 survey of 150 ASC perioperative and administrative leaders, 62% said staffing gaps caused cancelled or delayed cases in the past year and 53% closed rooms or cut operating days (Becker's ASC). That survey was sponsored by a sedation-staffing vendor, so treat the magnitude with some caution — but the direction matches what ASC administrators describe privately.

Medicare is moving the other way

If professional fees were catching up, the subsidy would be a bridge. They are not. The CY 2026 anesthesia conversion factor rose to $20.4976, a 0.88% increase, with a separate $20.5998 for Advanced APM participants (Ventra Health). That headline is misleading. CMS paired it with a 2.5% efficiency adjustment to work RVUs for non-time-based services and a 7% cut to facility-performed services, so the net expected effect on anesthesia revenue is roughly negative 1%.

2027 is proposed to go backwards outright. In the rule released July 14, 2026, the anesthesia conversion factor drops to $20.4165 for APM participants (a 0.88% cut) and $20.2143 for non-participants (a 1.38% cut), largely because the one-time 2.5% increase from the One Big Beautiful Bill Act expires. The ASA said it was “deeply disappointed” (ASA Washington Alert). A final rule is expected around November 1, 2026.

So the gap widens from both ends: labor cost up, public reimbursement flat to down. The stipend is what closes it.

What this means if you are an anesthesiologist

Physician anesthesiologists sit at the center of the arrangement because of billing mechanics, not sentiment. Under TEFRA (42 CFR 415.110), one anesthesiologist may medically direct up to four concurrent CRNA or CAA cases; at 1:4 the physician bills 50% and each anesthetist bills 50%, so the combined claim equals 100% of the base-plus-time calculation. Ratio changes therefore alter cost, not revenue (Guidestone). A group that cannot staff 1:4 — because of case complexity, room layout, or the seven TEFRA conditions — structurally loses margin, and that margin gap is exactly what the stipend negotiation is about.

Compensation is rising, but more slowly than the anesthetist lines. AMGA's survey of 3,635 organizational records put 2025 anesthesiologist median total clinical compensation at $536,320, up 5.5% year over year; other credible surveys for the same period range from $432,490 (BLS) to $565,540 (self-report platforms), a spread of more than $130,000 driven almost entirely by methodology (Becker's ASC). Anesthesiologist pay grew roughly 29% from 2019 to 2026.

Practical read: the leverage is in stipend structure, not base-salary benchmarking. Anesthesiologists negotiating a hospital contract in 2026 should be modeling fixed OR overhead — Surgical Directions benchmarks it near $2,300 per OR per day against typical adjusted utilization of 50–65% versus a 75% target (Becker's ASC) — because that is the number that determines whether the subsidy holds.

What this means if you are a CRNA

CRNAs have captured the fastest repricing in the market. Average CRNA compensation moved from roughly $181,000 in 2019 to about $288,000 in 2026 — 59% growth, roughly double the physician rate over the same window (Becker's ASC). AANA reports about 80% of CRNAs are being offered signing bonuses averaging around $20,000, and nearly one in five holds three or more contracts simultaneously (AANA).

The contingent shift is real: about 18% of actively practicing CRNAs work as independent contractors rather than employees (Becker's ASC), and most 1099 CRNAs now report earning $200–$249 per hour, with a quarter above $250 (APEX Anesthesia 2026 CRNA Career Report). Scope policy is moving the same direction: 27 states plus Guam have opted out of the federal Medicare physician-supervision requirement, with Vermont and Ohio joining in July 2026 (AANA opt-out fact sheet). Note that CMS's own public page still says nineteen — a discrepancy worth knowing before citing a number in a contract discussion.

The counterweight: UnitedHealthcare cut CRNA reimbursement 15% for personally performed services billed with the QZ modifier, effective for dates of service on or after October 1, 2025 (UnitedHealthcare policy bulletin). Labor-side rate growth and payer-side rate compression cannot both continue indefinitely.

What this means if you are a CAA

Certified anesthesiologist assistants are the smallest and fastest-appreciating pool. Headcount grew from roughly 500 in 2005 to more than 4,000 in 2025 (Stout). New-graduate economics are striking: average starting total compensation of about $239,000 on a $220,500 base, with an average sign-on bonus of $34,500 and $8,000 in relocation (Becker's ASC). Advertised ceilings broke through $330,000 in Q1 2026 (BagMask.com).

The binding constraint is licensure geography, not demand. Per the ASA, Tennessee became the 23rd state to authorize CAA practice when HB 979 was signed on May 21, 2025, in addition to Washington, D.C. and Guam (ASA news release) — though the CAA academy's own practice map still lists 22 states (AAAA). No new state enactment has been confirmed in 2026; bills remain pending in Minnesota, Maryland, Mississippi, Illinois, New York, and Kansas. Every CAA pay figure in circulation comes from job-posting analysis or self-report platforms, because the joint AAAA/NCCAA/ARC-AA compensation survey has not published results. Treat the ceilings as advertised, not realized.

Where the model bends next

Three things to watch. First, ASC tolerance. Hospitals can outbid ASCs on stipends because they can absorb the loss; ASCs cannot, and one ASC CEO has publicly described providers being paid a $4,000 daily stipend “just to walk in the door” (Becker's ASC). That is one anecdote, not a survey figure — but if ASC stipend expectations keep compounding at 2024–2025 rates, some centers will exit anesthesia-dependent case types entirely.

Second, ownership churn. Private equity's share of anesthesia practice acquisitions rose from roughly 20% in 2020 to about 33% by 2024, and the FTC announced an agreement in principle with U.S. Anesthesia Partners on April 23, 2026 to settle its Texas monopolization case (FTC). Meanwhile reverse consolidation is real — groups that sold in the 2015–2019 wave are buying themselves back, and physician-led entrants are scaling quickly (Becker's ASC).

Third, the pipeline. Anesthesiology filled 1,865 of 1,865 PGY-1 positions (100%) in the 2026 Match (NRMP) and cannot easily grow, because Medicare-funded GME slots have been capped since 1997 and eight states have no anesthesiology residency program at all. CRNA training lengthened from roughly 28 months to 36–51 as the doctoral requirement completed at the end of 2025. Neither pipeline expands fast enough to deflate stipends this decade.

The practical takeaway

If you run an OR or an ASC, stop modeling anesthesia as a break-even service line and start modeling it as a fixed access cost with a coverage guarantee attached. Build the stipend into per-OR-day economics, tie it to utilization targets, and recognize that ratio flexibility — 1:4 medical direction, or supervision where state law permits — is the only structural lever that moves cost without moving revenue.

If you are a clinician, pricing power currently sits in flexibility: contract structure, multi-site availability, and licensure portability are worth more in 2026 than an additional year of tenure. That is an uncomfortable equilibrium for everyone who wants stable coverage. It is also, for now, the market.

A note on the data

Anesthesia workforce statistics are unusually noisy. Compensation surveys disagree by six figures for the same specialty and year, BLS occupation pages were not directly retrievable at the time of writing, and there is no current neutral peer-reviewed cost-per-case comparison of care-team versus physician-only versus CRNA-led models — every quantified comparison available is either pre-2023 or advocacy-produced. Where sources conflict above, we have said so rather than averaging them.